在脑死亡器官捐赠者的器官采购优化中比较多巴胺和诺亚上腺素
Seongho Choi1, Min Ae Keum, Min Soo Kim
1From the Department of Trauma Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
概括
在脑死亡的器官捐赠者中,多巴胺占主导地位的血管压缩剂治疗显著增加了与北上腺素相比的肝脏采购率. 这种方法可以提高器官活力和移植成功.
科学领域:
- 关键护理医学 关键护理医学
- 移植免疫学 移植免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多巴胺和上腺素是管理冲击的关键血管压缩剂,包括脑死亡器官捐赠者.
- 有限的研究存在于脑死亡器官捐赠者的最佳血管压缩剂使用.
研究的目的:
- 确定在器官采购前24小时内对低血压脑死亡器官捐赠者最有效的血管压缩剂.
- 为了比较多巴胺占主导地位的血管压缩剂策略与北上腺素占主导地位的血管压缩剂策略的有效性.
主要方法:
- 对102个脑死亡器官捐赠者记录 (2010-2023) 的回顾性分析.
- 血管抑制剂使用量化使用血管活性无otropic 评分.
- 捐赠者被分为多巴胺占主导地位的群体和上腺素占主导地位的群体.
主要成果:
- 多巴胺占主导地位的组 (67名捐赠者) 显示肝脏采购率 (98.5%) 显著高于诺亚上腺素占主导地位的组 (35名捐赠者,80.0%;P = .002).
- 多变量分析证实,使用多巴胺 (OR 14.642;P = .015) 获得肝移植的几率更高.
结论:
- 多巴胺主导的血管压缩剂治疗与脑死亡器官捐赠者肝脏采购率的改善有关.
- 这一策略可能有助于缓解无氧代谢,可能提高移植器官的器官质量.
相关概念视频
Kidney Transplant I: Introduction
307
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
307
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K


